HTG Molecular
HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease
The company said that it saw growing demand for RUO sample processing services and consumables as development activities among its customer base picked up speed.
In Brief This Week: Becton Dickinson, Quidel, Lucid Diagnostics, AnchorDx, and 54gene
News items for the in vitro diagnostics industry for the week of July 19, 2021.
In Brief This Week: Hologic, NeoGenomics, Natera, Saga Diagnostics, and More
News items for the in vitro diagnostics industry for the week of June 14, 2021.
HTG Molecular Preliminary Q1 Revenues Fall 56 Percent
For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.
HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent
For the year ended Dec. 31, 2020, the firm reported revenues of $8.5 million compared to $19.2 million in 2019, beating the Wall Street estimate of $8.3 million.Â
Nov 23, 2020
HTG Molecular Completes 1-For-15 Reverse Stock Split
Jun 26, 2020
HTG Molecular Inks $10M Secured Credit Agreement
Aug 6, 2019